Skip to content

Clinical application of multimodal ultrasound in gynecologic cancer

Clinical application of multimodal ultrasound in gynecologic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081942
Enrollment
Unknown
Registered
2024-03-15
Start date
2023-07-10
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

Gold Standard: Postoperative histopathological examination.
Index test:1. multimodal ultrasound(including normal ultrasound examination,contrast-enhanced ultrasound examination and micro-vascular flow imaging examination

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Chinese female citizens, = 45 years old; 2. The patient has symptoms of abnormal vaginal bleeding; 3. Having postoperative pathology or endometrial biopsy as the gold standard; 4. Voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Postoperative surgical pathology time and ultrasound examination time>120 days; 3. Patients with a history of treating endometrial malignancies in the past; 4. The patient refuses to undergo transvaginal or transrectal ultrasound examination; 5. It is known that the subject is allergic to any component of the contrast agent.s.

Design outcomes

Primary

MeasureTime frame
Contrast-enhanced ultrasonography TIC;MV-flow ROI ratio;sensitivity;specificity;accuracy;area under the curve(ROC);

Countries

China

Contacts

Public ContactHuang Zeping

The Third Affiliated Hospital of Sun Yat-sen University

hzep@mail.sysu.edu.cn+86 135 8035 6169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026